scPharmaceuticals Inc. (SCPH)

scPharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	58.45	46.81	71.24	74.45	72	72.81
Short-Term Investments	0	29.2	47.13	1.01	33.28	0
Cash & Cash Equivalents	58.45	76.01	118.37	75.46	105.28	72.81
Cash Growth	-49.65%	-35.78%	56.86%	-28.32%	44.60%	-18.80%
Receivables	5.77	4.49	0	0	0	0
Inventory	9.57	8.84	1.23	0	0	0
Other Current Assets	2.73	3.6	3.71	2.82	2.55	2.84
Total Current Assets	76.53	92.94	123.31	78.28	107.83	75.65
Property, Plant & Equipment	1.41	1.46	0.62	0.48	0.91	1.31
Other Long-Term Assets	0.52	0.08	0.27	0.28	0.31	0.33
Total Long-Term Assets	1.93	1.54	0.89	0.76	1.22	1.64
Total Assets	78.45	94.48	124.2	79.04	109.05	77.28
Accounts Payable	2.71	4	1.52	0.54	1.67	1.14
Current Debt	0.18	0.18	0.57	10.28	2.87	0.41
Other Current Liabilities	9.43	8.96	5.33	4.02	4.79	3.69
Total Current Liabilities	12.32	13.13	7.42	14.85	9.32	5.24
Long-Term Debt	40.62	40.09	36.8	7.35	17.34	19.86
Other Long-Term Liabilities	0.95	4.03	7.55	0.37	0.22	0.82
Total Long-Term Liabilities	41.57	44.13	44.35	7.72	17.56	20.68
Total Liabilities	53.89	57.26	51.76	22.57	26.88	25.92
Total Debt	40.8	40.27	37.37	17.64	20.21	20.27
Debt Growth	8.30%	7.76%	111.90%	-12.72%	-0.29%	78.66%
Retained Earnings	-295.45	-281.35	-226.54	-189.7	-161.66	-129.46
Comprehensive Income	0	-0	0.03	-0	0	0
Shareholders' Equity	24.57	37.22	72.43	56.47	82.17	51.37
Net Cash / Debt	17.65	35.74	81	57.83	85.07	52.54
Net Cash / Debt Growth	-77.49%	-55.87%	40.08%	-32.03%	61.91%	-32.91%
Net Cash Per Share	0.45	0.93	2.86	2.11	3.46	2.82
Working Capital	64.21	79.8	115.89	63.43	98.51	70.41
Book Value Per Share	0.63	0.97	2.55	2.06	3.34	2.76

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).